Steven Johnson
- Role
-
Executive Vice President, Chief Development Officer
Experience
Steven was appointed to the position of Chief Development Officer at Zealand Pharma in June 2025. Steven brings nearly 30 years of experience driving drug development and regulatory strategy across the pharmaceutical industry. Most recently, Steven served as Senior Vice President and Head of Regulatory Stakeholders at UCB Biopharma, responsible for leading late phase clinical development, global regulatory affairs, biometrics and operational excellence. During Steven’s tenure at UCB, his teams secured global approvals for key therapies across multiple therapeutic areas. Previously he had senior leadership roles at Medpace, Inc. and at Novo Nordisk. Steven began his career at the U.S. Food and Drug Administration, where he served as a Master Reviewer in the Division of Metabolic and Endocrine Drug Products.
Education
Steven was a Geriatrics Fellow at Washington State University and holds a PharmD, a BPharm, and a BS in Biology, also from Washington State University.
